VectorBuilder, a global gene delivery solutions company, announced on April 11, 2022 the construction of a new $500 million R&D and manufacturing center in Guangzhou, China. The ‘Gene Delivery Research and Manufacturing Campus’ will aid in the growth of the company, expanding its R&D capabilities and production capacity for various gene delivery vectors.
The campus will include a state-of-the-art contract development and manufacturing organization facility designed for current good manufacturing practice manufacturing of plasmids, messenger RNA (mRNA), AAV, lentivirus, cell lines, and other types of viral and non-viral vectors. The campus will also house a research institution dedicated to developing new gene delivery techniques, vector-based vaccines, virus-based cancer therapeutics, and training for scientists and engineers joining the gene delivery field.
